eprosartan

Known as: Éprosartan, (e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid, 2-Thiophenepropanoic acid, alpha-((2-butyl-1-((4- carboxyphenyl)methyl)-lH-imidazol-5-yl)methylene)-, (E)- 
A competitive and reversible angiotensin II receptor antagonist with anti-hypertensive property. Eprosartan blocks the binding of angiotensin II to… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
BACKGROUND Recent data suggest that atenolol may be inferior to other antihypertensive drugs in reducing cardiovascular risk in… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Tissue accumulation of circulating prorenin results in angiotensin generation, but could also, through binding to the recently… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Studies in animals and humans indicate a role for kinins in the actions of angiotensin type 1 (AT1) receptor blockers… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
We evaluated the antihypertensive activity, glucose homeostasis and plasma lipid profile in patients with mild hypertension and… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Angiotensin type 1 receptor (AT(1)R) blockers (ARB) have been shown to reduce the incidence of type 2 diabetes… (More)
Is this relevant?
2004
2004
Enalapril and losartan reduce but not normalize sympathetic hyperactivity in patients with hypertensive chronic renal failure… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2003
2003
Antihypertensive agents are proven to reduce the cardiovascular risk of stroke, coronary heart disease and cardiac failure. The… (More)
Is this relevant?
2002
2002
BACKGROUND Experimental data in humans on the contribution of angiotensin-converting enzyme inhibitors and angiotensin II type 1… (More)
Is this relevant?
1998
1998
Activation of the renin-angiotensin system may contribute to the derangement in renal and cardiac function in congestive heart… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?